⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
SPRY Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ARS Pharmaceuticals Inc. Securities Class Action
globenewswire.com
SPRY
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SPRY
businesswire.com
SPRY
Class Action Lawsuit Alert: Levi & Korsinsky Reminds ARS Pharmaceuticals, Inc. (SPRY) Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
Pomerantz LLP Advises of Securities Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
prnewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
ROSEN, A TOP RANKED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Advises of Securities Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY